Skip to main content

MoneyWorks4Me

Bliss GVS Pharma informs about disclosure

22 Mar 2022 Evaluate

Bliss GVS Pharma has informed that the exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti V Rao & Vibha G Sharma.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1872.30
Dr. Reddys Labs. 1396.00
Cipla 1420.00
Lupin 1968.95
Zydus Lifesciences 1195.00
View more..